Weaning from Mechanical Ventilation
A systematic approach to ventilator liberation — from readiness assessment and spontaneous breathing trials to extubation and post-extubation monitoring.
Why Weaning Matters
Ventilator liberation — commonly called "weaning" — is the process of gradually reducing or discontinuing mechanical ventilatory support as the patient's condition improves. It is one of the most important daily tasks in critical care respiratory therapy.
Prolonged mechanical ventilation carries significant risks: ventilator-associated pneumonia (VAP), diaphragmatic atrophy and weakness from disuse (ventilator-induced diaphragm dysfunction), tracheal injury from the endotracheal tube, increased ICU length of stay, and higher mortality. Conversely, premature extubation leading to reintubation is also associated with increased morbidity and mortality.
The respiratory therapist is at the center of the weaning process — assessing readiness, conducting spontaneous breathing trials (SBTs), evaluating extubation tolerance, and monitoring post-extubation respiratory status.
Weaning Readiness Assessment
Before conducting an SBT, the patient should meet general criteria indicating the underlying cause of respiratory failure has been adequately addressed:
Underlying Cause
- Primary condition improving or resolved
- No active worsening of respiratory status
Oxygenation
- PaO₂ ≥ 60 mmHg on FiO₂ ≤ 0.40–0.50
- PEEP ≤ 8 cmH₂O
- SpO₂ ≥ 90%
Ventilatory Demand
- Spontaneous respiratory rate < 35/min
- Adequate spontaneous tidal volumes
- Stable minute ventilation
Hemodynamics
- No significant hemodynamic instability
- Minimal or no vasopressor support
- Heart rate < 140 bpm
Neurologic
- Adequate level of consciousness (follows commands)
- No pharmacologic sedation that impairs drive
- Cough and gag reflexes intact
Metabolic
- No severe electrolyte disturbances
- Temperature manageable
- Adequate nutritional support
Spontaneous Breathing Trial (SBT)
The spontaneous breathing trial is the most reliable predictor of successful extubation. It assesses whether the patient can sustain adequate ventilation with minimal or no ventilator support.
SBT Methods
T-Piece Trial
Patient breathes through the ETT connected only to humidified oxygen — no ventilator pressure support. Tests true spontaneous breathing effort but places higher demand on respiratory muscles. Most rigorous test.
CPAP/PSV with Low Support
Most common method. CPAP of 5 cmH₂O with PSV of 5–8 cmH₂O compensates for ETT resistance. Monitors breathing pattern and tolerance while still connected to the ventilator. If patient tolerates 30 minutes to 2 hours, extubation is considered.
Automatic Tube Compensation (ATC)
Ventilator automatically adjusts pressure to compensate for the calculated resistance of the ETT, approximating the work of breathing after extubation.
SBT Failure Criteria
The SBT should be stopped if the patient develops any of the following:
- Respiratory rate > 35 breaths/min for > 5 minutes
- SpO₂ < 90% or PaO₂ < 50–60 mmHg
- pH < 7.32 or rapid rise in PaCO₂
- Heart rate > 140 bpm or > 20% change from baseline
- Systolic BP > 180 or < 90 mmHg
- Increased work of breathing: diaphoresis, agitation, accessory muscle use
- Decreased level of consciousness or acute distress
Predictive Indices
Several indices have been developed to predict SBT success or failure before the trial:
Rapid Shallow Breathing Index (RSBI)
RSBI = f / VTf = respiratory rate; VT = tidal volume in liters. RSBI < 105 breaths/min/L predicts successful extubation in spontaneously breathing patients. Originally described by Yang and Tobin (1991). Limitation: does not account for respiratory muscle strength or airway secretions.
Maximum Inspiratory Pressure (MIP/NIF)
MIP more negative than -20 to -30 cmH₂OMeasures respiratory muscle strength. A more negative value indicates stronger inspiratory effort. NIF less negative than -20 suggests poor respiratory muscle reserve and higher reintubation risk.
Minute Ventilation
VE < 10 L/min at restHigh minute ventilation demands suggest the patient may not tolerate extubation. VE > 15 L/min is associated with higher failure rates.
Gradual Weaning Strategies
Most patients who pass an SBT can be extubated directly without a prolonged gradual weaning process. However, patients who fail initial SBTs may benefit from structured weaning approaches:
PSV Weaning
Gradually reduce PSV level over hours to days (e.g., from 14 to 10 to 8 to 6 to 5 cmH₂O), conducting SBTs at each level. Requires daily assessment and tolerance evaluation.
SIMV Rate Reduction
Reduce mandatory breath rate gradually while monitoring for respiratory distress. Less favored than PSV weaning based on current evidence, but still used in some protocols. Always combine with PSV for spontaneous breaths.
Daily SBT Protocol
Perform a 30-minute SBT every morning when the patient meets readiness criteria. Evidence shows daily SBT protocols with paired sedation interruption reduce ventilator days compared to gradual weaning strategies alone.
Extubation and Post-Extubation Care
After a successful SBT, extubation readiness must also include airway assessment. A cuff leak test (deflating the ETT cuff and listening for airflow around the tube) helps predict post-extubation stridor from subglottic edema, especially in patients intubated for extended periods.
Post-extubation monitoring should include SpO₂, respiratory rate, work of breathing, and ABG as indicated. High-flow nasal cannula (HFNC) used prophylactically after extubation in high-risk patients has been shown to reduce reintubation rates.
Common Post-Extubation Interventions
- Supplemental oxygen via nasal cannula or face mask titrated to SpO₂
- HFNC for high-risk patients (long intubation, cardiac/pulmonary history)
- Prophylactic NIV (BiPAP) for COPD or hypercapnic patients
- Racemic epinephrine nebulization for post-extubation stridor
- Secretion clearance: incentive spirometry, cough assistance, airway clearance therapy
Frequently Asked Questions
How long should an SBT last?
Most protocols use 30 minutes to 2 hours. A 30-minute SBT has comparable predictive value to a 2-hour SBT in most patients. If the patient tolerates the SBT without meeting failure criteria, extubation should be considered promptly.
What is the cuff leak test?
The cuff leak test involves deflating the ETT cuff and measuring the difference between delivered tidal volume and exhaled tidal volume, or audibly listening for air movement around the tube. A leak < 10% of delivered VT or absence of audible leak suggests subglottic edema and higher risk for post-extubation stridor.
What is prolonged weaning?
Prolonged weaning is defined as requiring more than 3 SBTs or weaning time exceeding 7 days after the first SBT. These patients typically have persistent respiratory muscle weakness, high secretion burden, neuromuscular disease, or an unresolved primary problem.
What happens if a patient fails extubation?
Reintubation within 48 hours is considered extubation failure. It is associated with higher mortality than patients who are never extubated or who are extubated successfully. The cause of failure should be identified before the next attempt — common causes include secretion burden, upper airway obstruction, cardiac dysfunction, and neuromuscular weakness.
Summary
- Daily assessment for weaning readiness reduces ventilator days and associated complications.
- An SBT (T-piece or low-pressure support) is the most reliable predictor of successful extubation.
- SBT failure criteria guide safe, objective decision-making during the trial.
- RSBI < 105 and NIF more negative than -20 cmH₂O support extubation readiness.
- Prophylactic HFNC after extubation reduces reintubation in high-risk patients.
- Identify and address the cause of weaning failure before attempting again.
Advanced References in RTB2
RTB2 offers faster bedside references and advanced tools inside the mobile app — including weaning readiness checklists, SBT tracking, and ventilator liberation protocols.
Related articles